A total of 633 biotechnology medicines for more than 100 diseases are currently in development, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). By therapeutic category, with some medicines counted in more than one category, the number of biotech medicines in development for cancer and related conditions, at 254, and infectious disease, at […]
Palo Atlo, CA 10/14/08—Varian has announced that it expects its sales for the fiscal year ended October 3 to exceed $1 billion. The company forecasts non-GAAP adjusted diluted EPS of more than $2.80, compared to previous guidance of $2.74 plus or minus $0.05. GAAP diluted EPS is expected to exceed $2.11, compared to the previous […]
Company Announcements Intellection appointed Beamtech Nordiska AB as its exclusive distributor for Sweden, Scandinavia and the Baltic States. Leica Microsystems CMS GmbH named Dr. Stefan Traeger managing director in June. Leica Microsystems CMS GmbH’s Life Science reorganized into three strategic business units in June: Life Science Research, Clinical Imaging and Nanotechnology. FEI will market and […]
Venlo, the Netherlands 10/1/08; Uppsala, Sweden 10/1/08—QIAGEN NV has acquired the assets of the Biosystems business and the remaining 17.5% of Corbett Life Science (see IBO 7/15/08) from Biotage AB for approximately $53 million in cash and performance milestone payments of up to $7 million over four years. The Biosystems business develops and sells the […]
French biotechnology companies have 73 products in early-stage development and 98 drugs in clinical development, according to France Biotech. Ten drugs are awaiting market approval and four are on the market. Despite economic conditions and a weak IPO market, France Biotech expects French biotech firms to be able to obtain funding through alliances or mergers […]
A recent report prepared by the US Government Accountability Office (GAO) found that the FDA’s monitoring of fresh produce is deficient. In fiscal 2007, the FDA spent a minimum of $20.2 million, approximately 3% of its food safety expenditures, on fresh produce oversight. The FDA’s Office of Regulatory Affairs accounted for 82% of this spending, […]
Company Announcements During fiscal year 2008, Applied Biosystems discontinued the manufacture of the 433A Peptide Synthesis and the Procise Protein Sequencing systems, but will continue to provide support for existing systems for five years. Oxford Nanopore Technologies announced in August an exclusive agreement to develop and commercialize nanopore technologies developed at Harvard University, the University […]
Company Announcements Picarro named Iain Green director of Marketing in June. He was previously senior marketing manager of NMR products for Varian. Picarro also appointed Mark Davis as vice president of Sales. He was previously director of US Sales for Hach. Picarro named new two distributors: Sanyo Trading for Japan and KNJ Engineering for South […]
Santa Clara, CA 10/13/08—Affymetrix has announced that it expects third-quarter revenues to be approximately $75 million, compared to $95.0 million last year. Analysts had forecasted revenues of $90.1 million, according to Thomson Financial. The company does not provide revenue guidance on a quarterly basis. Affymetrix attributed the shortfall to greater competition for research funding and […]
Carlsbad, CA 10/9/08; 10/15/08—Invitrogen announced it has amended the terms of its merger agreement with Applied Biosystems (ABI). To allow the companies’ stockholders to consider the amendment, the meetings to vote on the merger will take place October 28, instead of October 16. The amendment eliminates the requirement that the parties receive certain opinions regarding […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
